SCHEMBL8712817

SCHEMBL8712817

Cn1nnc2ccc(C(NNC=O)c3ccc(Cl)cc3)cc21

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.50
CYP11B1 P15538 1/20 0.50
KEAP1 Q14145 4/20 0.44
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.34
CHRM4 P08173 1/20 0.34
SLC9A1 P19634 1/20 0.34
SLC6A4 P31645 1/20 0.33
FAAH O00519 1/20 0.33
KMO O15229 1/20 0.33
NSD2 O96028 1/20 0.32
MAPK1 P28482 1/20 0.32
S1PR3 Q99500 1/20 0.32
HCAR3 P49019 1/20 0.32
NOTUM Q6P988 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8714052 0.81 CYP19A1 (0.55) CYP19A1CYP11B1KEAP1NPC1RAB9A
Hydrochloric Acid SCHEMBL8710447 0.80 CYP19A1 (0.54) CYP19A1CYP11B1KEAP1NPC1RAB9A
SCHEMBL8884360 0.75 CYP19A1 (0.60) CYP19A1CYP11B1KEAP1NPC1RAB9A
SCHEMBL9026711 0.74 CYP19A1 (0.58) CYP19A1CYP11B1KEAP1NPC1RAB9A
SCHEMBL8712814 0.74 CYP19A1 (0.50) CYP19A1CYP11B1KEAP1NPC1RAB9A
Bromide SCHEMBL8884686 0.73 CYP19A1 (0.57) CYP19A1CYP11B1KEAP1NPC1RAB9A
SCHEMBL14476937 0.71 KEAP1 (0.53) CYP19A1CYP11B1KEAP1NPC1RAB9A
SCHEMBL3873020 0.69 CYP19A1 (0.59) CYP19A1CYP11B1KEAP1NPC1RAB9A
SCHEMBL15341829 0.68 CYP19A1 (0.50) CYP19A1CYP11B1KEAP1NPC1RAB9A
SCHEMBL9027055 0.68 CYP19A1 (0.66) CYP19A1CYP11B1KEAP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5746840-A Process for preparing enantiomerically pure 6-{4-chlorophenyl) (1 H-1,2,4-triazol-1-YL) methyl}-1-methyl-1 H-benzotriazole JANSSEN PHARMACEUTICA, N.V. (BE) 1998-05-05 US disclosed
US-5663354-A Process for preparing enantiomerically pure 6-[(4-chlorophenyl) (1H-1,2,4-triazol-1-yl) methyl]-1-methyl-1H-benzotrizole JANSSEN PHARMACEUTICA, N.V. (BE) 1997-09-02 US disclosed
EP-0668861-A1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE 6- (4-CHLOROPHENYL)(1H --TRIAZOL-1,2,4-TRIAZOL-1-YL)METHYL]-1-METHYL-1H --BENZOTRIAZOLE JANSSEN PHARMACEUTICA N.V. (BE) 1995-08-30 EP disclosed
WO-1994011364-A1 PROCESS FOR PREPARING ENANTIOMERICALLY PURE 6-[(4-CHLOROPHENYL)(1H^_-TRIAZOL-1,2,4-TRIAZOL-1-YL)METHYL]-1-METHYL-1H^_-BENZOTRIAZOLE JANSSEN PHARMACEUTICA N.V. (BE) 1994-05-26 WO disclosed